Redox nanodrugs alleviate chronic kidney disease by reducing inflammation and regulating ROS
Biomaterials Science · 2024 · 12 (24) · 6403-6415
DOI: 10.1039/d4bm00881b ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials Science, 2024. Verfasst von Qin Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shenzhen University General Hospital, Shenzhen University, Shenzhen, Guangdong, 518000, China. wangqinmail@vip.163.com. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Renal Insufficiency, Chronic, Rats, Sprague-Dawley, Doxorubicin. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Beijing Municipality, Shenzhen Science and Technology Innovation Commission.
Abstract (Originalsprache)
A novel ultrasmall redox-active nanodrug (Tac@C-Mn 3 O 4 ) protected mitochondria, scavenged excess ROS, maintained cellular redox homeostasis, and inhibited the oversecretion of pro-inflammatory cytokines, thereby restoring renal function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Shenzhen University General Hospital, Shenzhen University, Shenzhen, Guangdong, 518000, China. wangqinmail@vip.163.com.
- Department of Neurology, South China Hospital, Medical School, Shenzhen University, Shenzhen, Guangdong, 518116, China.
- CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, 100190, China. wenting.shang@ia.ac.cn.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Beijing Municipality
- Shenzhen Science and Technology Innovation Commission
Zitieren
APA
Wang, Q., Nie, X., Song, Y., Qiu, H., Chen, L., Zhu, H., Zhang, X., Yang, M., Xu, X., Chen, P., Zhang, C., Xu, J., Ren, Y., & Shang, W. (2024). Redox nanodrugs alleviate chronic kidney disease by reducing inflammation and regulating ROS. Biomaterials Science, 12(24), 6403-6415. https://doi.org/10.1039/d4bm00881b
Vancouver
Wang Q, Nie X, Song Y, Qiu H, Chen L, Zhu H, et al. Redox nanodrugs alleviate chronic kidney disease by reducing inflammation and regulating ROS. Biomaterials Science. 2024;12(24):6403-6415. doi:10.1039/d4bm00881b
BibTeX
@article{Wang2024,
author = {Wang, Qin and Nie, Xuedan and Song, Yifan and Qiu, Haiyan and Chen, Liting and Zhu, He and Zhang, Xueli and Yang, Mengru and Xu, Xiaohui and Chen, Peidan and Zhang, Chao and Xu, Jia and Ren, Yeping and Shang, Wenting},
title = {Redox nanodrugs alleviate chronic kidney disease by reducing inflammation and regulating ROS},
journal = {Biomaterials Science},
year = {2024},
volume = {12},
number = {24},
pages = {6403--6415},
doi = {10.1039/d4bm00881b}
}
EUVIMED